Delivery Order SPE2DR25D3505-SPE2DR26F96M9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,312.13 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,944.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,397.53 for 100 tablets of Concerta ER 36 mg on December 8, 2025, with completion expected by December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,446.16 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is...
- The Defense Logistics Agency awarded a $1,580.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The order will be fulfilled from...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta 36mg, with a ceiling value of $3,715.96. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. The delivery order represents a single pharmaceutical procurement transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,365.08 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,160.28 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Concerta ER 54 mg tablets (100 count units). This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was competitively awarded without set-aside provisions. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $1,957.34. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F96M9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,878.13 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on January 6, 2026, with completion scheduled for January 7, 2026. The award was competitively procured with no set-aside designation and utilizes firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The product will be delivered to the Conshohocken location. This delivery order represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply prescription medications, generic and brand-name drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Concerta ER is a controlled-release methylphenidate formulation used for attention deficit hyperactivity disorder treatment, reflecting the company's role in supplying specialty pharmaceuticals across multiple therapeutic domains to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/5/26 |